Researchers at MIT have developed an advanced microfluidic system that encompasses tissues from up to 10 organs. The device allows scientists to test the effects of drug candidates on multiple organ systems simultaneously. Screening drug candidates in this way reduces the chance of unexpected side-effects during subsequent clinical trials, and red (Read more...)